Table 1.
p value 3 groups (Kruskal–Wallis) | SLT | iStent inject® | Trabectome® | |
---|---|---|---|---|
Age (years) | ||||
N | < 0.001 | 105 | 130 | 107 |
Mean ± SD | 65.2 ± 11.9 | 73.4 ± 9.5 | 71.2 ± 10.8 | |
Gender (%) | ||||
Male | 0.031 | 29.5 | 45.4 | 36.6 |
Female | 70.5 | 54.6 | 66.4 | |
Eye (%) | ||||
OD | < 0.001 | 49.5 | 44.2 | 46.7 |
OS | 50.5 | 55.8 | 53.3 | |
IOP (mmHg) | ||||
N | < 0.001 | 105 | 129 | 105 |
Mean ± SD | 17.9 ± 3.5 | 20.2 ± 6.1 | 23.3 ± 4.8 | |
Medication | ||||
N | < 0.001 | 105 | 130 | 90 |
Mean ± SD | 1.7 ± 1.20 | 2.3 ± 1.1 | 2.5 ± 0.9 | |
CDR | ||||
N | < 0.001 | 99 | 55 | 33 |
Mean ± SD | 0.6 ± 0.2 | 0.8 ± 0.2 | 0.6 ± 0.2 | |
RNFL global (µm) | ||||
N | < 0.001 | 93 | 23 | 31 |
Mean ± SD | 81.9 ± 16.3 | 75.1 ± 20.2 | 67.8 ± 19.6 |
SLT selective laser trabeculoplasty, IOP intraocular pressure, medication number of glaucoma medications, RNFL retinal nerve fiber layer, CDR cup to disc ratio, mean ± SD